# Sylvant

NDC: 73090-421
Generic name: Siltuximab
Labeler / Manufacturer: Recordati Rare Diseases, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140423

FDA application: BLA125496

## Active ingredients

- SILTUXIMAB: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73090-421"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73090-421
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d663642-f52e-49c0-a023-2da083fdfc0b